Eye Med Distributor Lobs $100M Suit Over Supply Contract

Law360, New York (September 12, 2012, 8:48 PM EDT) -- Eye medicine distributor Fera Pharmaceuticals LLC lodged trade secrets, unfair competition and breach of contract claims against Akorn Inc. in New York state court Wednesday, seeking at least $100 million in damages over allegations that Akorn broke the terms of a supply deal.

Fera, which markets and distributes anti-infective eye medicines, alleges that Akorn agreed in 2009 to manufacture and supply products marketed by Fera — including bacitracin and erythromycin eye ointments — but did not abide by the terms of the contract, the suit said....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.